Skip to main content
. 2022 Mar 2;19(4):1191–1208. doi: 10.1021/acs.molpharmaceut.1c00988

Table 1. Formulation for Dissolving MAP Preparation.

drug components (%w/w)
ibuprofen sodium 30% drug, 20% w/w of aqueous polymer blend (PVA (9–10 kDa) and PVP (58 kDa)), 50% surfactant solution
ibuprofen sodium (control) 30% drug, 20% w/w of aqueous polymer blend (PVA (9–10 kDa) and PVP (58 kDa)), 50% deionized water
itraconazole 15% drug, 45% w/w of aqueous polymer blend (PVA (9–10 kDa) and PVP (58 kDa)), 40% surfactant solution
itraconazole (control) 15% drug, 45% w/w of aqueous polymer blend (PVA (9–10 kDa) and PVP (58 kDa)), 40% deionized water